Wabtec Reports First Quarter 2025 Results; Announces Increase in Full-Year EPS Guidance
GAAP Diluted Earnings Per Share of $1.88, Up 22.9%; Adjusted Diluted Earnings Per Share of $2.28, Up 20.6% GAAP Operating Margin at 18.2%; Adjusted Operating Margin... Read more.
Central Pacific Financial Reports First Quarter 2025 Earnings of $17.8 Million
Highlights include: Net income of $17.8 million, or $0.65 per diluted share Return on average assets of 0.96% and return on average equity of 13.04% Efficiency ratio... Read more.
REPLY S.p.A.: Shareholders’ Meeting Approves the 2024 Financial Statements
Consolidated turnover of €2,295.9 million (€2,118.0 million in 2023); Group net profits of €211.1 million (€186.7 million in 2023) The proposal to distribute... Read more.
Aurion Biotech Appoints Edward J. Holland, M.D., as Chief Medical Officer and Eris P. Jordan, O.D., as Chief Development Officer
Key leadership appointments to accelerate global clinical development of AURN001, a transformational cell therapy for corneal endothelial disease SEATTLE & CAMBRIDGE,... Read more.
Summit Bank Group Reports 2025 1st Quarter Earnings
EUGENE, Ore.–(BUSINESS WIRE)–Summit Bank Group (OTC Pink: SBKO) Q1 2025 Net Income of $2.93 million or $0.37 per fully diluted share; an increase of... Read more.
Desired Effect Launches First Vuln/Exploit Ethical Market – Brings Defenders to the Pre-Attack Buying Pool, Strips Attackers of Cheap Exploits and First-Mover Edge
Defenders Gain True Pre-Attack Intel, Independent Researchers Gain Greater Rewards, Recognition. SAN FRANCISCO & BALTIMORE–(BUSINESS WIRE)–#DesiredEffect—Desired... Read more.
Thermo Fisher Scientific Reports First Quarter 2025 Results
WALTHAM, Mass.–(BUSINESS WIRE)–Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for... Read more.
Hexnode and Kite Partner to Strengthen Endpoint Management Across the UK
This partnership follows the opening of Hexnode’s UK quarters on the 29th floor of London’s architectural masterpiece, the Gherkin skyscraper. LONDON–(BUSINESS... Read more.
Mursla Bio Receives FDA Breakthrough Device Designation for EvoLiver Test
Reflects the potential of EvoLiver test to improve early liver cancer detection among high-risk patients EvoLiver leverages Mursla Bio’s platform based on organ-specific... Read more.
FICO and dacadoo Partner to Bring AI-Powered Precision to Life Insurance
Alliance will give insurers more flexible and precise risk assessment for life insurance, enabling greater targeting and personalized offers ZURICH & BOZEMAN,... Read more.